Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Imprimis Phar (IMMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,940
  • Shares Outstanding, K 21,050
  • Annual Sales, $ 26,770 K
  • Annual Income, $ -11,990 K
  • 36-Month Beta -0.42
  • Price/Sales 2.20
  • Price/Cash Flow N/A
  • Price/Book 15.72

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.71 +2.58%
on 09/17/18
3.39 -17.99%
on 08/23/18
-0.41 (-12.85%)
since 08/21/18
3-Month
1.99 +39.70%
on 06/28/18
3.39 -17.99%
on 08/23/18
+0.47 (+20.35%)
since 06/21/18
52-Week
1.35 +105.93%
on 11/02/17
3.39 -17.99%
on 08/23/18
+1.10 (+65.48%)
since 09/21/17

Most Recent Stories

More News
Consolidated Research: 2018 Summary Expectations for FTD Companies, PRA Group, Equity Bancshares, ConforMIS, Immune Design, and Imprimis Pharmaceuticals -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of FTD Companies, Inc. (NASDAQ:FTD),...

IMMY : 2.78 (-0.71%)
EQBK : 40.79 (+0.32%)
CFMS : 1.18 (-4.84%)
FTD : 2.75 (-8.03%)
PRAA : 38.85 (unch)
IMDZ : 3.50 (-1.41%)
Imprimis: 2Q Earnings Snapshot

SAN DIEGO (AP) _ Imprimis Pharmaceuticals Inc. (IMMY) on Monday reported second-quarter earnings of $2.5 million.

IMMY : 2.78 (-0.71%)
Imprimis Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 6, 2018 / Imprimis Pharmaceuticals, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 6, 2018 at 4:30 PM Eastern...

IMMY : 2.78 (-0.71%)
Imprimis Announces Multi-Center Clinical Trial for Dropless® TriMoxi(TM) (Triamcinolone Acetonide-Moxifloxacin for injection) Formulation in Canada

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) through its ImprimisRx ophthalmology business today announced its Canadian partner, Advanced Dosage Forms Inc., will begin enrolling patients at McGill University...

IMMY : 2.78 (-0.71%)
Imprimis Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 6, 2018

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today announced it will release second quarter 2018 financial results after the close of trading on Monday, August 6, 2018. The company will host a conference...

IMMY : 2.78 (-0.71%)
Imprimis: 1Q Earnings Snapshot

SAN DIEGO (AP) _ Imprimis Pharmaceuticals Inc. (IMMY) on Tuesday reported a loss of $3.5 million in its first quarter.

IMMY : 2.78 (-0.71%)
Imprimis Pharmaceuticals Announces First Quarter 2018 Results

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today reported financial results for the first quarter 2018.

IMMY : 2.78 (-0.71%)
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners

Surface Pharmaceuticals, Inc., an affiliated company of Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), today announced it has entered into a definitive stock purchase agreement with an affiliate of Flying...

IMMY : 2.78 (-0.71%)
Research Report Identifies Albany International, JBG SMITH Properties, Preferred Apartment Communities, National Western Life Group, Phibro Animal Health, and Imprimis Pharmaceuticals with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Albany International Corporation...

APTS : 17.32 (+1.35%)
NWLI : 319.76 (-0.36%)
IMMY : 2.78 (-0.71%)
AIN : 78.20 (-0.89%)
JBGS : 37.55 (+0.19%)
PAHC : 42.30 (-2.65%)
Imprimis Pharmaceuticals to feature its patent-pending cyclosporine/chondroitin sulfate and patented non-opioid MKO Melt® (midazolam/ketamine/ondansetron) formulations at the upcoming Cataract & Refractive Surgery Medical Meeting

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), and its ophthalmology-focused ImprimisRx division, today announced its participation and related physician presentations at the 2018 American Society of Cataract...

IMMY : 2.78 (-0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade IMMY with:

Business Summary

Imprimis Pharmaceuticals, Inc. is a pharmaceutical company focused on its proprietary ophthalmology and urology drug formulations. Imprimis recently launched its urology business, which includes a patented formulation to address patients suffering from interstitial cystitis.

See More

Key Turning Points

2nd Resistance Point 2.89
1st Resistance Point 2.84
Last Price 2.78
1st Support Level 2.73
2nd Support Level 2.67

See More

52-Week High 3.39
Last Price 2.78
Fibonacci 61.8% 2.61
Fibonacci 50% 2.37
Fibonacci 38.2% 2.13
52-Week Low 1.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar